Latest Breaking News On - Adaptive biotechnologies company profile - Page 1 : comparemela.com

Adaptive Biotechnologies Co (NASDAQ:ADPT) Receives $6 80 Average Price Target from Analysts

Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average […]

Kyle piskelStacyl taylorAdaptive biotechnologies coAdaptive biotechnologies company profilePinnacle wealth planning services incJpmorgan chase coAdaptive biotechnologies corporationGoldman sachs groupFirst trust direct indexingSecurities exchange commissionManchester capital managementAdaptive biotechnologiesGet free reportMarketbeat ratingsExchange commissionCapital management

Adaptive Biotechnologies (NASDAQ:ADPT) Announces Earnings Results

Adaptive Biotechnologies (NASDAQ:ADPT) Announces Earnings Results
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Julie rubinsteinSecurities exchange commissionAdaptive biotechnologies company profileJpmorgan chase coAdaptive biotechnologies corporationGoldman sachs groupAdaptive biotechnologiesGet free reportPresident julie rubinsteinExchange commissionBiotechnologies corporationAdaptive biotechnologies daily

Adaptive Biotechnologies (NASDAQ:ADPT) Issues Quarterly Earnings Results

Adaptive Biotechnologies (NASDAQ:ADPT) Issues Quarterly Earnings Results
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Kyle piskelAdaptive biotechnologies company profileGoldman sachs groupAdaptive biotechnologies corporationJpmorgan chase coAdaptive biotechnologiesGet free reportBiotechnologies corporationAdaptive biotechnologies daily

Adaptive Biotechnologies Co (NASDAQ:ADPT) Given Average Rating of Moderate Buy by Brokerages

Adaptive Biotechnologies Co (NASDAQ:ADPT) Given Average Rating of Moderate Buy by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesStacyl taylorGoldman sachs groupAdaptive biotechnologies corporationMassachusetts financial services coJpmorgan chase coSecurities exchange commissionInvestment managementAdaptive biotechnologies company profileAdaptive biotechnologies coAdaptive biotechnologiesGet free reportMarketbeat ratingsExchange commissionCapital managementMassachusetts financial services

Adaptive Biotechnologies Co (NASDAQ:ADPT) Holdings Lowered by Peregrine Capital Management LLC

Peregrine Capital Management LLC reduced its holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT – Free Report) by 14.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 375,638 shares of the company’s stock after selling 64,317 shares during the quarter. Peregrine Capital Management LLC […]

Stacyl taylorAdaptive biotechnologies corporationFinancial services group incHealthcare of ontario pension plan trust fundMetlife investment managementJpmorgan chase coExchange commissionAdaptive biotechnologies coMeeder asset management incGoldman sachs groupAdaptive biotechnologies company profilePeregrine capital managementSecurities exchange commissionAdaptive biotechnologiesFree reportCapital management